Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Kodiak Sciences Inc in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211951
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | $(58,158) | $(57,461) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 4,109 | 4,603 |
| Stock-based compensation | 12,155 | 15,891 |
| Loss on disposal of long-lived assets | — | 8 |
| Non-cash lease impairment expense | — | 1,910 |
| Amortization of operating lease right-of-use asset | 2,231 | 2,125 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Kodiak Sciences Inc's D&A?
- Kodiak Sciences Inc (KOD) reported D&A of $4.11M in Q1 2026.
- How has Kodiak Sciences Inc's D&A changed year-over-year?
- Kodiak Sciences Inc's D&A decreased by 10.7% year-over-year, from $4.6M to $4.11M.
- What is the long-term trend for Kodiak Sciences Inc's D&A?
- Over 4 years (2021 to 2025), Kodiak Sciences Inc's D&A has grown at a 106.8% compound annual growth rate (CAGR), from $1M to $18.33M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Kodiak Sciences Inc's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude